Lilly to Donate Insulin KwikPens To Support Lower-Income Communities

Published on
By : dLife Editors

Starting this month, Eli Lilly and Company will donate at least 200,000 KwikPens® to three relief organizations – Americares, Direct Relief and Dispensary of Hope – to stock insulin at nearly 200 U.S. free clinics through 2022.

These donations will directly support lower-income people living with diabetes who qualify for free clinic services.

Separately, Lilly is providing $2 million to fund grants that relief agencies will distribute to a wide range of eligible free clinics. The grants will fund programs intended to help people with diabetes understand and access resources that can help them obtain medicine and supplies, medical care, insurance coverage and more.

The insulin donations include KwikPens of Humalog® (insulin lispro injection 100 units/mL), Humalog® Mix75/25 (insulin lispro protamine and insulin lispro injectable suspension), and Basaglar® (insulin glargine injection 100 units/mL).

Shipments to relief agencies have already started, giving lower-income people another option for accessing insulin.

“Dispensary of Hope is excited to expand the ongoing effort with Lilly’s insulin donation program,” said Chris Palombo, Dispensary of Hope CEO. “Insulin saves lives, and the addition of donated Humalog and Basaglar KwikPens is important for the nation’s uninsured, low-income community.”

In 2018, Lilly announced plans to donate insulin vials to stock approximately 150 U.S. free clinics. Since then, Lilly has donated 120,000 vials that have been used by people who qualify for free clinic services. Lilly is now sending KwikPens to the relief agencies for distribution to nearly 200 free clinics.

“This donation of KwikPens will help many people across the U.S. get the treatment they need,” said Mike Mason, president, Lilly Diabetes. “With the help of the relief agencies, Lilly insulin will now be available in many free clinics that are equipped to properly store it.”

These donations are part of a broader suite of solutions that Lilly is providing to people who need help affording their insulin.

These options include lower-priced versions of branded insulins, out-of-pocket price caps at pharmacies for people with commercial insurance plans and help for people with immediate needs.

Anyone who uses a Lilly insulin can call the Lilly Diabetes Solution Center at (833) 808-1234 (9 a.m. to 8 p.m. EST Monday through Friday) to see whether there is an option that reduces their out-of-pocket costs, including information about how to receive free insulin through a free clinic if they meet income requirements.

More information about the grants that relief agencies will receive can be found on the Lilly company website.


  1. Eli Lilly and Company. (2020, Jan. 29). Lilly plans a donation of 200,000 insulin KwikPens over the next three years to support lower-income communities. PR Newswire. Retrieved Jan. 29, 2020 from